Loading company…
Riskpilot
← Back to search
Sign in
Get full access
STAR PHARMA AS
AS
Active
Org 927816784
Bjørumsvegen 15, 5627 Jondal
Retail sale of other food · NACE 4727
Est. 2021
0 employees
Watchlist
Share
Download PDF
Full Risika report
Overview
Financials
People & ownership
Related companies
Revenue 2024
NOK 2M
+141% vs 2023
EBITDA margin
12.5%
+290% vs 2023
Equity ratio
19.4%
Financial strength
Net profit 2024
NOK 226K
+266% vs 2023
EBITDA — year on year
NOK millions
0M
0M
1M
1M
1M
0M
2021
0M
0%
2022
0M
0%
2023
0M
0%
2024
Key figures
Annual report 2024
Revenue
NOK 2M
+141%
EBITDA
NOK 252K
+290%
Net profit
NOK 226K
+266%
Total assets
NOK 664K
+126%
Equity
NOK 129K
+232%
Employees
0
—
Company information
Legal name
STAR PHARMA AS
Org number
927816784
Legal form
Aksjeselskap
NACE code
4727 · Retail sale of other food
Founded
27. september 2021
Share capital
NOK 30 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Netthandel. Salg av vitamimer og helsekostprodukter, samt annen virksomhet som naturlig faller inn under dette.
Contact
Address
Bjørumsvegen 15, 5627 Jondal
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Retail sale of other food
Companies in Ullensvang
All Norway companies
Revenue
NOK millions
0M
1M
1M
2M
2M
0M
2021
0M
2022
1M
2023
2M
2024
EBITDA
NOK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
Income statement
NOK thousands
Item
2021
2022
2023
2024
Revenue
0
232
839
2 025
Staff expenses
−0
−0
−0
−0
EBITDA
−0
19
−133
252
Depreciation & amort.
−0
−0
−0
−0
EBIT
−0
19
−133
252
Net financials
0
−2
−3
−1
Profit before tax
−0
17
−136
252
Tax
−0
2
−0
25
Net profit
−0
14
−136
226
Balance sheet
NOK thousands
Item
2021
2022
2023
2024
Total assets
30
146
294
664
Equity
24
39
−97
129
Long-term debt
0
0
0
0
Short-term debt
6
107
391
535
Total debt
6
107
391
535
Financial ratios
5-year trend
EBITDA margin
12.5%
This company
15.8%
Market median
-21% vs market
2021
2024
Equity ratio
19.4%
This company
38.2%
Market median
-49% vs market
2021
2024
Return on equity
175.6%
This company
18.4%
Market median
+854% vs market
2021
2024
Net profit margin
11.2%
This company
8.1%
Market median
+38% vs market
2021
2024
Asset turnover
3.05×
This company
1.12×
Market median
+172% vs market
2021
2024
Debt / equity
4.16×
This company
0.62×
Market median
-571% vs market
2021
2024
Annual reports & filings
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-08-18 – 2021-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Age
Other directorships
PB
Pål Bentsrud
Chief Executive Officer
Chief Executive Officer
2022
—
—
Board of directors
Non-executive oversight
Name
Role
Member since
Age
Other directorships
MB
Michaela Bentsrud
Chairman
2021
—
—
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Petrichor As
Company
33.4%
33.4%
2022
Univital As
Company
33.3%
33.3%
2022
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
Univital As
STAR PHARMA AS
(this company)
Board network connections
Board members of STAR PHARMA AS also hold positions in
0
other companies.
Person
Role here
Other companies
Pål Bentsrud
Chief Executive Officer
0 companies
Michaela Bentsrud
Chairman
0 companies